The Nutritional Magnesium Association noted magnesium is an essential nutrient that helps absorb necessary nutritional supplements like vitamin D or calcium in response to a recent U.S. Preventive Services Task Force report that suggested supplementing with these ingredients may not help prevent bone fractures in postmenopausal women, while also increasing the risk of kidney stones.
CVS Caremark has announced the extension of its Pharmacy Advisor program to cover an additional five chronic conditions, including asthma, breast cancer, chronic obstructive pulmonary disease, depression and osteoporosis.
A JAMA report released suggested a high intake of supplemental calcium is associated with an increased risk of cardiovascular disease death in men was criticized by several dietary supplement agencies for being inconclusive.
The Council for Responsible Nutrition on Wednesday announced it is partnering with the National Osteoporosis Foundation in hosting a free webinar for pharmacists and nurse practitioners around updated recommendations and research of calcium and vitamin D.
A biotech drug made by Eli Lilly for osteoporosis appeared no more or less effective than a pharmaceutical drug available as a generic in treating women with related bone fractures, but was more effective in some other measures, according to results of a late-stage clinical trial released Tuesday.
The Council for Responsible Nutrition on Thursday issued a response to a U.S. Preventive Services Task Force draft recommendation around the ineffectiveness of vitamin D and calcium to prevent cancer or fractures.
A study recently published in the Endocrine Society’s Journal of Clinical Endocrinology and Metabolism suggests that vitamin D — when taken with calcium — can reduce the rate of mortality in seniors, thereby providing a possible means of increasing life expectancy, the society reported Friday.
CVS/pharmacy announced on Wednesday the launch of Project Health (Proyecto Salud in Spanish), a wellness program delivering more than $21 million worth of free health screenings to multicultural communities.
Soy isoflavone tablets do not appear to be associated with a reduction in bone loss or menopausal symptoms in women within the first five years of menopause, according to a report in the Aug. 8 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Overweight or obese women who have less-than-optimal levels of vitamin D and lose more than 15% of their body weight experience significant increases in circulating levels of this fat-soluble nutrient, according to a study released last week by researchers at Fred Hutchinson Cancer Research Center.